mRNA analysis of genes responsible for idiopathic hypogonadotrophic hypogonadism

Cover Page

Abstract


Background. Hypogonadotropic hypogonadism (HH) is a disorder characterized by delayed or absent pubertal development due to pathology of the hypothalamic-pituitary-gonadal axis. HH may be both congenital (Kallmann’s syndrome) and sporadic. Congenital or isolated HH is divided into with anosmia/hyposmia (KS) and with normal olfaction (nIHH). Nowadays several tens of genes involved in the functioning of the reproductive axis are known. However DNA lesions can be found just in 5-15% of such cases of HH.

Aim. So we decided to measure mRNA expression of several genes which can be found in leukocytes of peripheral blood - namely GNRHR and GNRH1 (are necessary for adequate biological effect of GnRH); PROK2 and CHD7 (are responsible for the migration of GnRH neurons), WDR11 and DUSP6 (are involved in normal sexual development).

Methods. A quantitative determination of mRNA expression of these genes were comlpeted in the fresh peripheral blood sample by PCR in real time.

Results. Examined patients: 9 women with hypogonadotropic hypogonadism (age from 18 to 28 y.o.); duration of the disease from 2 to 15 years; 3 of them – amenorrhea I and 6 – amenorrhea II. Reasons of amenorrhea II were: stress, excessive exercises, rapid body weight loss, past use of oral contraceptives. The control group: 19 healthy women; age from 19 to 37 y.o.; with regular ovalutory menstrual cycle, some of them have children. mRNA expression of examined genes differed from normal patterns in each case of hypogonadotropic hypogonadism. Changes in GNRHR, GNRH1 and DUSP6 mRNA expression were found in most of cases. However variations of mRNA expression were multidirectional in each case and there was no similarity among expression profiles of patients according to amenorrhea type or anamnestic factors.

Conclusions. According to our preliminary results, in women with hypogonadotropic hypogonadism the functional activity damage of “reproductive-responsible” genes could be found in each case. Probably mRNA expression measuring could be a perspective method for proving hypothalamo-pituitary level of reproductive disorders and may help to determine which genes should be tested for DNA impairment.


Anna S. Loktionova

Moscow Regional Research and Clinical Institute named after M.F. Vladimirskiy

Author for correspondence.
Email: ann-lok@yandex.ru

Russian Federation Trainee (Department of therapeutic Endocrinology)

Natela G Eneva

Lomonosov Moscow State University

Email: prtsceen@gmail.com

Russian Federation PhD- student (Department of Genetics)

Karina A. Khusniyarova

Lomonosov Moscow State University

Email: karina.khusniyarova@gmail.com

Russian Federation Bachelor of Science (Department of Genetics)

Lidia N Nefedova

Lomonosov Moscow State University

Email: lidia_nefedova@mail.ru

Russian Federation Doctor of Science (Department of Genetics)

Alexander I. Kim

Lomonosov Moscow State University

Email: aikim57@mail.ru

Russian Federation Doctor of Science, professor (Department of Genetics)

Alexander V. Dreval

Moscow Regional Research and Clinical Institute named after M.F. Vladimirskiy

Email: dreval@diabet.ru

Russian Federation MD, PhD, professor (Department of therapeutic Endocrinology)

Irena A. Ilovayskaya

Moscow Regional Research and Clinical Institute named after M.F. Vladimirskiy

Email: irena.ilov@yandex.ru

Russian Federation MD, PhD (Department of therapeutic Endocrinology)

Views

Abstract - 1496

PDF (English) - 204

Cited-By


PlumX

Dimensions


Copyright (c) 2016 Loktionova A.S., Eneva N.G., Khusniyarova K.A., Nefedova L.N., Kim A.I., Dreval A.V., Ilovayskaya I.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies